Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Doxoves-LNP Doxorubicin HCl,Doxoves®-doxorubicin hydrochloride liposomes |
| Catalog Number | R-ZZTBSSDL-117 |
| Alias | Doxorubicin hydrochloride long circulation liposome |
| Appearance | Dark red transparent or slightly opalescent uniform liquid |
| Molecular Formula | N/A |
| Solubility | It is a hydrocolloid dispersible injection that can be directly diluted with normal saline or 5% glucose injection. |
| Storage | 4°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | Control standards for nanomedicine pharmacokinetics and biodistribution studies |
| Specification | 10mg:Inquiry 20mg:Inquiry 50mg:Inquiry |
| Description | Doxoves-LNP Doxorubicin HCl is a PEGylated long-circulation liposome injection that uses advanced nanotechnology to encapsulate doxorubicin hydrochloride. It is a model of the third generation of liposome chemotherapy drugs. Its prescription is based on long-circulation liposome technology (usually using HSPC/Chol/DSPE-mPEG2000 or similar components). Doxorubicin hydrochloride is encapsulated in the aqueous phase of the liposome with a high encapsulation rate (>95%) through an active drug loading method (such as ammonium sulfate gradient) to form a stable nanodrug reservoir. |